Published in Dev Cell on January 19, 2010
Neural tube defects. Annu Rev Neurosci (2014) 1.69
Protease-activated receptor 2 signaling in inflammation. Semin Immunopathol (2011) 1.47
Grainyhead-like 2 regulates neural tube closure and adhesion molecule expression during neural fold fusion. Dev Biol (2011) 1.45
The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment. Biochem J (2010) 1.27
Membrane-anchored serine proteases in vertebrate cell and developmental biology. Annu Rev Cell Dev Biol (2011) 1.26
The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors. J Biol Chem (2010) 1.24
Tissue factor and cell signalling in cancer progression and thrombosis. J Thromb Haemost (2011) 1.20
c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase. Oncogene (2011) 1.18
In toto live imaging of mouse morphogenesis and new insights into neural tube closure. Development (2012) 1.16
Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation. PLoS Genet (2012) 1.16
Membrane-anchored serine proteases in health and disease. Prog Mol Biol Transl Sci (2011) 1.13
A matriptase-prostasin reciprocal zymogen activation complex with unique features: prostasin as a non-enzymatic co-factor for matriptase activation. J Biol Chem (2013) 1.09
PAR2 absence completely rescues inflammation and ichthyosis caused by altered CAP1/Prss8 expression in mouse skin. Nat Commun (2011) 1.09
Prostasin is required for matriptase activation in intestinal epithelial cells to regulate closure of the paracellular pathway. J Biol Chem (2013) 1.05
Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol (2010) 1.00
Mechanisms of tissue fusion during development. Development (2012) 0.99
Expression and genetic loss of function analysis of the HAT/DESC cluster proteases TMPRSS11A and HAT. PLoS One (2011) 0.96
Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis. Oncogene (2014) 0.95
Activation of protease-activated receptor 2 induces VEGF independently of HIF-1. PLoS One (2012) 0.94
The channel-activating protease CAP1/Prss8 is required for placental labyrinth maturation. PLoS One (2013) 0.92
Cofactoring and dimerization of proteinase-activated receptors. Pharmacol Rev (2013) 0.92
How to form and close the brain: insight into the mechanism of cranial neural tube closure in mammals. Cell Mol Life Sci (2012) 0.92
Endogenous expression of matriptase in neural progenitor cells promotes cell migration and neuron differentiation. J Biol Chem (2010) 0.88
The membrane-anchored serine protease prostasin (CAP1/PRSS8) supports epidermal development and postnatal homeostasis independent of its enzymatic activity. J Biol Chem (2014) 0.86
Fate Specification of Neural Plate Border by Canonical Wnt Signaling and Grhl3 is Crucial for Neural Tube Closure. EBioMedicine (2015) 0.86
Imaging a functional tumorigenic biomarker in the transformed epithelium. Proc Natl Acad Sci U S A (2012) 0.86
Epithelial fusion during neural tube morphogenesis. Birth Defects Res A Clin Mol Teratol (2012) 0.86
The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin. J Biol Chem (2014) 0.86
The role of palmitoylation in signalling, cellular trafficking and plasma membrane localization of protease-activated receptor-2. PLoS One (2011) 0.85
Activity and inhibition of prostasin and matriptase on apical and basolateral surfaces of human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol (2012) 0.85
A GRHL3-regulated repair pathway suppresses immune-mediated epidermal hyperplasia. J Clin Invest (2014) 0.84
Matriptase activation connects tissue factor-dependent coagulation initiation to epithelial proteolysis and signaling. Blood (2016) 0.83
Proteolytic activation of the protease-activated receptor (PAR)-2 by the glycosylphosphatidylinositol-anchored serine protease testisin. J Biol Chem (2014) 0.83
TMPRSS13 deficiency impairs stratum corneum formation and epidermal barrier acquisition. Biochem J (2014) 0.81
Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model. Cancer Sci (2013) 0.81
A balance between TFPI and thrombin-mediated platelet activation is required for murine embryonic development. Blood (2015) 0.80
Matriptase autoactivation is tightly regulated by the cellular chemical environments. PLoS One (2014) 0.80
Matriptase is inhibited by extravascular antithrombin in epithelial cells but not in most carcinoma cells. Am J Physiol Cell Physiol (2011) 0.80
Defining a PARticular pathway of neural tube closure. Dev Cell (2010) 0.79
Regulation of feto-maternal barrier by matriptase- and PAR-2-mediated signaling is required for placental morphogenesis and mouse embryonic survival. PLoS Genet (2014) 0.79
Rho GTPases in embryonic development. Small GTPases (2014) 0.79
Detection of active matriptase using a biotinylated chloromethyl ketone peptide. PLoS One (2013) 0.78
Regulation of cell protrusions by small GTPases during fusion of the neural folds. Elife (2016) 0.78
Grainyhead-like 2 downstream targets act to suppress epithelial-to-mesenchymal transition during neural tube closure. Development (2016) 0.78
Diabetic complications in pregnancy: is resveratrol a solution? Exp Biol Med (Maywood) (2013) 0.78
Hepatocyte growth factor activator inhibitor-1 is induced by bone morphogenetic proteins and regulates proliferation and cell fate of neural progenitor cells. PLoS One (2013) 0.77
New insights into sodium transport regulation in the distal nephron: Role of G-protein coupled receptors. World J Biol Chem (2016) 0.76
Neural tube closure: cellular, molecular and biomechanical mechanisms. Development (2017) 0.76
Delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin. Development (2016) 0.76
Dynamic behaviors of the non-neural ectoderm during mammalian cranial neural tube closure. Dev Biol (2016) 0.75
G-protein-coupled receptor signaling and neural tube closure defects. Birth Defects Res A Clin Mol Teratol (2016) 0.75
Ibuprofen regulates the expression and function of membrane-associated serine proteases prostasin and matriptase. BMC Cancer (2015) 0.75
Natural Endogenous Human Matriptase and Prostasin Undergo Zymogen Activation via Independent Mechanisms in an Uncoupled Manner. PLoS One (2016) 0.75
PAR2-dependent activation of GSK3β regulates the survival of colon stem/progenitor cells. Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Spina Bifida: Pathogenesis, Mechanisms, and Genes in Mice and Humans. Scientifica (Cairo) (2017) 0.75
The E3 ubiquitin ligase Hace1 is required for early embryonic development in Xenopus laevis. BMC Dev Biol (2016) 0.75
Interference with protease-activated receptor 1 does not reduce damage to subventricular zone cells of immature rodent brain following exposure to blood or blood plasma. J Negat Results Biomed (2015) 0.75
Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity. PLoS One (2017) 0.75
Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell (1991) 11.51
Thrombin signalling and protease-activated receptors. Nature (2000) 9.27
Expression of a Delta homologue in prospective neurons in the chick. Nature (1995) 5.73
The genetic basis of mammalian neurulation. Nat Rev Genet (2003) 4.14
Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest (1999) 3.16
Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature (2001) 3.15
Role of the thrombin receptor in development and evidence for a second receptor. Nature (1996) 3.12
Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol (2004) 3.03
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A (2000) 3.01
Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene (2002) 2.74
Rac1 is required for the formation of three germ layers during gastrulation. Oncogene (1998) 2.61
A role for thrombin receptor signaling in endothelial cells during embryonic development. Science (2001) 2.55
PAR3 is a cofactor for PAR4 activation by thrombin. Nature (2000) 2.55
Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem (2000) 2.50
The epidermal barrier function is dependent on the serine protease CAP1/Prss8. J Cell Biol (2005) 2.36
Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron (2004) 2.23
Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J Clin Invest (2007) 2.20
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study. Lancet (2009) 2.13
Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation. J Biol Chem (2006) 2.07
Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc Natl Acad Sci U S A (2001) 2.07
Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci (2001) 2.06
Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proc Natl Acad Sci U S A (1999) 2.01
Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J Pharmacol Exp Ther (1999) 2.01
Embryonic cardiomyocyte hypoplasia and craniofacial defects in G alpha q/G alpha 11-mutant mice. EMBO J (1998) 1.96
Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes Dev (2005) 1.92
Hepsin promotes prostate cancer progression and metastasis. Cancer Cell (2004) 1.89
A dominant inhibitory version of the small GTP-binding protein Rac disrupts cytoskeletal structures and inhibits developmental cell shape changes in Drosophila. Development (1995) 1.83
Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med (2009) 1.83
The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J Biol Chem (2003) 1.71
PARticipation in inflammation. J Clin Invest (2003) 1.70
Mechanisms of neurulation: traditional viewpoint and recent advances. Development (1990) 1.64
Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway. Am J Pathol (2009) 1.62
Embryonic folate metabolism and mouse neural tube defects. Science (1998) 1.56
Tissue factor pathway inhibitor and the revised theory of coagulation. Annu Rev Med (1995) 1.54
Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway. Proc Natl Acad Sci U S A (2007) 1.52
Inositol- and folate-resistant neural tube defects in mice lacking the epithelial-specific factor Grhl-3. Nat Med (2003) 1.51
Co-localization of the channel activating protease prostasin/(CAP1/PRSS8) with its candidate activator, matriptase. J Cell Physiol (2007) 1.51
Development of the vertebrate central nervous system: formation of the neural tube. Prenat Diagn (2009) 1.49
Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. Eur J Biochem (2001) 1.49
Matriptase: potent proteolysis on the cell surface. Mol Med (2006) 1.47
Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice. Development (2009) 1.38
Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells. J Biol Chem (2002) 1.36
Spatial and temporal expression of the Grainyhead-like transcription factor family during murine development. Gene Expr Patterns (2006) 1.35
Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development. Am J Pathol (1994) 1.35
Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity. J Biol Chem (2008) 1.31
Review article: proteinase-activated receptors - novel signals for gastrointestinal pathophysiology. Aliment Pharmacol Ther (2000) 1.30
Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. J Biol Chem (2003) 1.29
The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells. Biochem J (2005) 1.27
Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition. Am J Physiol Cell Physiol (2009) 1.27
Essential role for Galpha13 in endothelial cells during embryonic development. Proc Natl Acad Sci U S A (2005) 1.22
Increased expression of Grainyhead-like-3 rescues spina bifida in a folate-resistant mouse model. Hum Mol Genet (2007) 1.15
Potent and selective inhibition of membrane-type serine protease 1 by human single-chain antibodies. Biochemistry (2003) 1.12
Structure of an Fab-protease complex reveals a highly specific non-canonical mechanism of inhibition. J Mol Biol (2008) 1.09
Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis. J Invest Dermatol (2002) 1.08
Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs). Biol Chem (2006) 1.07
Ultrastructural observations on closure of the neural tube in the mouse. Anat Embryol (Berl) (1979) 1.04
Topographical changes along the neural fold associated with neurulation in the hamster and mouse. Am J Anat (1976) 1.03
Hepatocyte growth factor activator inhibitor-1 has a complex subcellular itinerary. Biochem J (2008) 1.02
Combined deficiency of protease-activated receptor-4 and fibrinogen recapitulates the hemostatic defect but not the embryonic lethality of prothrombin deficiency. Blood (2003) 1.00
Modulation of Rho GTPase activity in endothelial cells by selective proteinase-activated receptor (PAR) agonists. J Thromb Haemost (2003) 0.98
Modeling neural tube defects in the mouse. Curr Top Dev Biol (2008) 0.93
Regulated shedding of PAR1 N-terminal exodomain from endothelial cells. J Biol Chem (2004) 0.90
Do cells become homeless during neural tube closure? Cell Cycle (2009) 0.81
Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science (2007) 6.04
Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc Natl Acad Sci U S A (2011) 3.80
Global landscape of HIV-human protein complexes. Nature (2011) 3.70
Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr (2003) 3.49
Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues. Arthritis Rheum (2010) 3.45
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer. J Clin Oncol (2005) 3.22
Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202 (alliance). J Clin Oncol (2014) 3.16
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. J Biol Chem (2007) 3.07
Anatomical profiling of G protein-coupled receptor expression. Cell (2008) 2.88
Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection. Nature (2011) 2.71
Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development (2004) 2.68
Combinatorial regulation of endothelial gene expression by ets and forkhead transcription factors. Cell (2008) 2.60
Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood (2004) 2.45
High-resolution crystal structure of human protease-activated receptor 1. Nature (2012) 2.44
Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest (2009) 2.41
Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963. J Clin Invest (2007) 2.36
Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. J Exp Med (2009) 2.34
A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest (2008) 2.26
TMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulation. Cell (2012) 2.24
Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J Clin Invest (2007) 2.20
Palmitoylation is required for the production of a soluble multimeric Hedgehog protein complex and long-range signaling in vertebrates. Genes Dev (2004) 2.16
Recommendations for clinical trials of off-label drugs used to treat advanced-stage cancer. J Clin Oncol (2012) 2.15
Overview of the Alliance for Cellular Signaling. Nature (2002) 2.15
Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation. J Biol Chem (2006) 2.07
Substrate profiling of cysteine proteases using a combinatorial peptide library identifies functionally unique specificities. J Biol Chem (2006) 2.05
Clinical analysis of paraneoplastic encephalitis associated with ovarian teratoma. J Neurooncol (2007) 2.03
Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis. Proc Natl Acad Sci U S A (2006) 1.95
Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor. EMBO J (2004) 1.94
Trapping moving targets with small molecules. Science (2009) 1.86
PAR1 cleavage and signaling in response to activated protein C and thrombin. J Biol Chem (2005) 1.83
A universal telomerase RNA core structure includes structured motifs required for binding the telomerase reverse transcriptase protein. Proc Natl Acad Sci U S A (2004) 1.83
Mycobacterium tuberculosis MycP1 protease plays a dual role in regulation of ESX-1 secretion and virulence. Cell Host Microbe (2010) 1.76
Albumin binding as a general strategy for improving the pharmacokinetics of proteins. J Biol Chem (2002) 1.76
Protection against thrombosis in mice lacking PAR3. Blood (2002) 1.74
Characterization of matriptase expression in normal human tissues. J Histochem Cytochem (2003) 1.74
Engineering of a macromolecular scaffold to develop specific protease inhibitors. Nat Biotechnol (2003) 1.73
The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J Biol Chem (2003) 1.71
DGAT1-dependent triacylglycerol storage by macrophages protects mice from diet-induced insulin resistance and inflammation. J Clin Invest (2010) 1.70
A fat body-derived IGF-like peptide regulates postfeeding growth in Drosophila. Dev Cell (2009) 1.69
Adhesion signaling by a novel mitotic substrate of src kinases. Oncogene (2005) 1.68
Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide. Biol Blood Marrow Transplant (2008) 1.67
mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo. Mech Dev (2003) 1.66
Olfactory receptor antagonism between odorants. EMBO J (2003) 1.66
CYP306A1, a cytochrome P450 enzyme, is essential for ecdysteroid biosynthesis in the prothoracic glands of Bombyx and Drosophila. J Biol Chem (2004) 1.65
Wnt/β-catenin signaling is differentially regulated by Gα proteins and contributes to fibrous dysplasia. Proc Natl Acad Sci U S A (2011) 1.62
Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature (2013) 1.61
Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis. Gastroenterology (2007) 1.60
Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood (2003) 1.57
HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. Am J Physiol Cell Physiol (2005) 1.56
Life-threatening hemolytic anemia due to an autoanti-Pr cold agglutinin: evidence that glycophorin A antibodies may induce lipid bilayer exposure and cation permeability independent of agglutination. Transfusion (2009) 1.53
Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine. Proc Natl Acad Sci U S A (2010) 1.52
Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway. Proc Natl Acad Sci U S A (2007) 1.52
Hepatocyte growth factor is a preferred in vitro substrate for human hepsin, a membrane-anchored serine protease implicated in prostate and ovarian cancers. Biochem J (2005) 1.51
Mdm2 and p53 are highly conserved from placozoans to man. Cell Cycle (2010) 1.51
Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest (2012) 1.51
Gata4 expression in lateral mesoderm is downstream of BMP4 and is activated directly by Forkhead and GATA transcription factors through a distal enhancer element. Development (2005) 1.51
Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase. Proc Natl Acad Sci U S A (2006) 1.50
Health disparities in staging of SEER-medicare prostate cancer patients in the United States. Urology (2010) 1.50
Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood (2007) 1.49
Odorant response assays for a heterologously expressed olfactory receptor. Biochem Biophys Res Commun (2003) 1.49
High busulfan exposure is associated with worse outcomes in a daily i.v. busulfan and fludarabine allogeneic transplant regimen. Biol Blood Marrow Transplant (2008) 1.46
Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms. J Immunol (2005) 1.46
Identification of minimal enhancer elements sufficient for Pax3 expression in neural crest and implication of Tead2 as a regulator of Pax3. Development (2004) 1.46
Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters. Clin Cancer Res (2002) 1.44
Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice. J Clin Invest (2011) 1.44
Effect of urologists and medical oncologists on treatment of elderly men with Stage IV prostate cancer. Urology (2011) 1.44
Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J (2006) 1.42
The unique evolution of neuropeptide genes in the silkworm Bombyx mori. Insect Biochem Mol Biol (2008) 1.42
A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1. Cancer Epidemiol Biomarkers Prev (2006) 1.41
A multi-enzyme cascade of hemoglobin proteolysis in the intestine of blood-feeding hookworms. J Biol Chem (2004) 1.41
Neverland is an evolutionally conserved Rieske-domain protein that is essential for ecdysone synthesis and insect growth. Development (2006) 1.41
The sphingosine 1-phosphate receptor S1P₂ maintains the homeostasis of germinal center B cells and promotes niche confinement. Nat Immunol (2011) 1.39
Pre-existing chiasma syndromes do not entirely remit following transsphenoidal surgery for pituitary adenomas. Acta Neurochir (Wien) (2010) 1.39
Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer. Dev Biol (2004) 1.37
Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells. J Biol Chem (2002) 1.36
Genome of multidrug-resistant uropathogenic Escherichia coli strain NA114 from India. J Bacteriol (2011) 1.33
Roles of protease-activated receptors in a mouse model of endotoxemia. Blood (2006) 1.32
A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer. Cancer Res (2010) 1.32
Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences. J Biol Chem (2006) 1.31